Cancers

Apr 9, 2021| Posted in: Cancers, Drug Development, Treatment

The History of Sarcoma Treatment Development

Roman Grosiberg, MD, Medical Oncologist and Director of…
Apr 7, 2021| Posted in: Autoimmune / Autoinflammatory Disorders, Cancers, Skin Conditions

Overview of Cutaneous Lymphoma

Susan Thornton, CEO of Cutaneous Lymphoma Foundation, gives…
Apr 7, 2021| Posted in: Cancers, Diagnosis, Endocrine Disorders, Metabolic Disorders

Diagnosing Acromegaly

Roberto Salvatori, MD, Medical Director, Johns Hopkins Pituitary…
Apr 6, 2021| Posted in: Autoimmune / Autoinflammatory Disorders, Cancers

Overview of Cutaneous T-cell Lymphoma

Anne Wood Beaven, MD, Associate Professor of Medicine…
Apr 2, 2021| Posted in: Cancers, Drug Development, Treatment

Two Strategies for Developing Rare Cancer Clinical Trials

Roman Grosiberg, MD, Medical Oncologist and Director of…
Apr 1, 2021| Posted in: Autoimmune / Autoinflammatory Disorders, Cancers, Treatment

Choosing the Right Treatment for Cutaneous T-cell Lymphomas

Anne Wood Beaven, MD, Associate Professor of Medicine…
Mar 31, 2021| Posted in: Cancers, Endocrine Disorders, Metabolic Disorders, Treatment

Acromegaly Treatment Options

Lawrence S. Kirschner, MD, PhD, Professor of Medicine,…
Mar 30, 2021| Posted in: Advocacy, Autoimmune / Autoinflammatory Disorders, Cancers

How the Cutaneous Lymphoma Foundation Helps Patients

Susan Thornton, CEO of Cutaneous Lymphoma Foundation, gives…
Mar 29, 2021| Posted in: Cancers, Drug Development, Regulations, Treatment

FDA Approves CAR-T Cell Immunotherapy for Relapsed/Refractory Multiple Myeloma

The U.S. Food and Drug Administration (FDA) has…
Mar 25, 2021| Posted in: Cancers, Endocrine Disorders, Metabolic Disorders, Treatment

Treatment Options for Acromegaly

Roberto Salvatori, MD, Medical Director, Johns Hopkins Pituitary…

Tenosynovial Giant Cell Tumor (TGCT)

Tenosynovial giant cell tumor (TGCT) is a non-malignant tumor involving the joint synovium, bursae, and tendon sheath. These rare tumors are sometimes referred to as giant cell tumor of the tendon sheath (GCT-TS) and/or pigmented villonodular synovitis (PVNS).

Neuroendocrine Tumors (NETs) Research Highlights: CME Program

Edward M Wolin, MD from the Tisch Cancer Institute at Mount Sinai and Icahn School of Medicine at Mount Sinai, highlights the latest information about NETs and provides expert analysis of its clinical relevance for busy members of the care team in order to help them care for patients with these rare diseases.

Cutaneous T-Cell Lymphoma Learning Center

Cutaneous T-cell lymphoma (CTCL) belongs to the non-Hodgkin lymphoma class of hematologic T-cell lymphoproliferative disorders. It is a rare group of malignancies, with an incidence of 6.4 cases per 1 million people.

Rare Disease Clinical Trials CME Program

Learn about clinical trials and rare diseases through these brief courses that are certified for CME and CNE credit.
  • Heather Lau, MD, MS, NYU School of Medicine, New York, NY
  • Morie A Gertz, MD, Mayo Clinic, Rochester, MN
  • Timothy Craig, DO, Penn State University, Hershey, PA
  • Eric T. Wong, MD, Harvard Medical School, Boston, MA

CME Program: Gaucher Disease Highlights from WORLDSymposium 2020

Neal Weinreb, MD, FACP highlights the latest information about Gaucher disease from WORLDSymposium and provides expert analysis of its clinical relevance to help health care providers better care for patients with this rare disease.

CME Program: Mucopolysaccharidoses (MPSs) Highlights from WORLDSymposium 2020

Barbara K. Burton, MD highlights the latest information about MPSs from WORLDSymposium and provides expert analysis of its clinical relevance for members of the care team in order to help them care for patients with these rare diseases.

Cancers

Topics